Eton Pharmaceutcials, Inc. Common Stock
Symbol: ETON (NASDAQ)
17.72
▲ (0.88%) 0.154
Company Description:
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Key Stats
- Today's Open: $17.6
- Today's High: $17.724
- Today's Low: $17.6
- Today's Volume: 0
- Yesterday Close: $17.57
- Yesterday High: $18.04
- Yesterday Low: $17.22
- Yesterday Volume: 215.66K
- Last Min Volume: 0
- Last Min High: $17.724
- Last Min Low: $17.6
- Last Min VWAP: $0
Company Profile
- Name: Eton Pharmaceutcials, Inc. Common Stock
- Website: https://www.etonpharma.com
- Listed Date: 2018-11-14
- Location: DEER PARK, IL
- Market Status: Active
- CIK Number: 0001710340
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $467.16M
- Round Lot: 100
- Outstanding Shares: 26.82M
- Asset Type: CS
RECENT FILINGS FOR ETON
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-20 | 4 | View |
| 2025-08-19 | 144 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-08 | 8-K | View |
| 2025-06-27 | 8-K | View |
| 2025-06-20 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 144 | View |
| 2025-06-10 | 8-K | View |
| 2025-06-05 | 4 | View |
| 2025-06-03 | 144 | View |
| 2025-05-28 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-05-02 | 8-K/A | View |
| 2025-04-28 | 8-K | View |
| 2025-04-25 | DEF 14A | View |
Latest News on ETON